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Abstract
Background: Swaziland has the highest HIV prevalence in the world and the highest estimated tuberculosis
incidence rate in the world. An estimated 80% of TB patients are also infected with HIV. TB detection through
intensified case finding (ICF) has yet to become a routine aspect of integrated tuberculosis and HIV care. The
purpose of this study was to evaluate implementation of ICF for TB into routine integrated tuberculosis and HIV
care at 16 community clinics and one district hospital in Swaziland.
Methods: Nurses and lay counsellors conducted ICF using a TB screening tool and patient pathway at all HIV
service entry points in clinics and the hospital. The patient pathway had three-stages; screening, sputum smear
diagnosis and TB treatment initiation. Outcomes and losses to follow up were monitored at each stage. Patient
demographics, access, and service feasibility and effectiveness were compared at hospital and clinic sites.
Results: 1467 HIV patients at clinics and the hospital were screened over a 3 month period. Large losses to follow
up occurred prior to the sputum diagnosis stage; only 47% (n = 172) of TB suspects provided a specimen. 28 cases
of smear positive TB were diagnosed and 24 commenced treatment. People screened at clinics were significantly
more likely to be female, older, and from rural or geographically remote areas (p < 0.001). There was no significant
difference between the hospital and clinics sites in the proportion of all participants screened who were smear
positive (x2 = 1.909; p = 0.16). The number needed to screen to detect one sputum positive TB case was 34 at
clinics and 63 at the district hospital.
Conclusions: ICF was operationally feasible and became established as a routine aspect of tuberculosis and HIV
integrated care. ICF in community clinics was potentially more accessible to an underserved, rural population and
was as effective as the hospital service in detecting smear positive TB.
Background
Tuberculosis remains the leading cause of morbidity and
mortality amongst people living with HIV/AIDS world-
wide [1]. Of the 1.37 million people with active TB who
are also co-infected with HIV worldwide, 80% live in
Sub-Saharan Africa [2]. In 2007 the tuberculosis case
detection rate in the Africa Region was 47%. This
remains far short of the Global Stop TB Strategy target
of 70% of incident smear-positive cases detected and
treated in DOTS programmes [3]. Passive case finding
through directly observed short-course strategy (DOTS)
is no longer seen as an adequate response to the rising
TB incidence rates within generalised HIV epidemics
[4,5].
A response to this global challenge was outlined by
the World Health Organisation (WHO) in its “Three Is”
policy: Intensified case finding (ICF), isoniazid preven-
tion therapy (IPT), and infection control [6]. ICF aims
to provide early detection thus increasing the chance of
survival in TB infected individuals. ICF is also an impor-
tant public health intervention, by aiming to reduce dis-
ease within health services and community settings,
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reduced [5-7]. Despite this, scaled up delivery has pro-
gressed slowly with estimates from 2008 showing only
4.1% of HIV positive people screened for TB [8]. Lack
of data to inform policies, poor system infrastructure
and concerns about feasibility and human resources
have constrained wider implementation in high HIV
prevalence settings [5,9].
Swaziland has the highest HIV prevalence in the world
with 26% of the adult population infected [9] and the
highest estimated TB incidence rate in the world at
1,198 per 100,000[10]. An estimated 80% of TB patients
are also infected with HIV [10]. The high HIV preva-
lence and TB/HIV co-infection rates pose serious chal-
lenges to health care delivery systems. Despite national
guidance encouraging ICF in all HIV testing and coun-
selling settings, detection has yet to become a routine
part of TB/HIV integrated care [10]. This is especially
true at the primary care level where most people first
make their debut into the healthcare system through
HIV testing. Additional constraints include human
resources and a limited number of TB laboratory diag-
nostic facilities [11,12].
This study implemented and evaluated a programme
of ICF into a high HIV prevalence, low resource, rural
setting. The objectives were to determine whether ICF
was operationally feasible in the hospital and clinic set-
tings, to measure and compare outcomes at both sites,
examine the barriers to access, and assess the potential
for scale up of ICF.
Methods
Setting
Implementation took place in the Lubombo region; the
poorest and most rural region in Swaziland with popula-
tion of 208,000. The ICF programme was implemented at
the one district hospital which serves the region and the
16 community clinics which provided HIV services. The
other clinics within the region which did not provide
routine HIV testing or follow up care were not involved.
Prior to this study, community clinics did not provide
TB screening. TB diagnosis and treatment was provided
at the district hospital’s TB unit, with some community
clinics involved in TB treatment follow up. TB care was
not integrated within HIV services. In the hospital TB
care had been partially integrated within HIV care when
patients were screened for TB as part of their com-
mencement of ART. However, in both the district hos-
pital and the community clinics, TB screening was not
routinely or systematically provided to patients who
were receiving HIV testing or follow up pre ART care.
The district hospital TB diagnostic services included
smear microscopy and X-ray. Prior to the study, HIV
services at the district hospital included provider
initiated HIV testing and ART treatment. ART com-
mencement was provided by a physician on the basis of
WHO clinical staging, CD4 results and patient adher-
ence to treatment.
HIV and TB services were provided separately and TB
screening and investigations were not routinely provided
in HIV testing and pre-ART care. Patients commencing
and receiving ART had some screening through the
physician but this was not formally recorded or
monitored.
In community clinics, prior to the study, partial HIV
services were provided. This included provider initiated
HIV testing and CD4 counts, via weekly transportation
system from the district hospital to the clinics. Patients
commenced on ART at the district hospital were eligible
for “ART Roll out” care at the community clinics. This
consisted of routine follow-up care and medication
refills at the clinics through the service. Routine TB
screening or diagnosis was not provided at community
clinics. Instead, patients were referred to the district
hospital for microscopy and X-ray.
ICF programme design
The ICF programme included four elements: ICF path-
way and screening tool (Figure 1); staff training; trans-
portation system for sputum specimens and smear
results; and a reporting and monitoring system.
A three-stage patient pathway (Figure 1) was designed
which included: 1) TB screening all HIV patients attend-
ing care; 2) laboratory diagnosis and patient notification;
and 3) TB treatment initiation for all sputum-smear
positive cases. Nurses and lay counsellors used a five-
question screening tool validated by the Swaziland Min-
istry of Health to assess TB symptoms at each HIV
diagnosis, pre-ART care and treatment visit. The screen-
ing tool had already been introduced into some ART
services across the country as part of TB/HIV integrated
care. People with symptoms of TB were requested to
submit two sputum specimens (one spot and one morn-
ing sputum) for smear microscopy for acid-fast bacilli
(AFB). Those at the district hospital were requested to
return the following day with sputum specimens. At
clinic sites patients were asked to return specimens by
the date of the bi-monthly specimen collection. Patients
screened at the hospital returned after five days to col-
lect smear results. Clinic patients with sputum-smear
positive results were informed by telephone, via the
community clinic or home visit by outreach worker, ide-
ally within five days. Negative results were returned at
the next bi-monthly transportation. All sputum-smear
positive cases were instructed to come to the district
hospital in order to commence TB treatment.
Staff training consisted of a standardised two day
training course for nurses and HIV counsellors at clinics
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National TB screening tool and ICF pathway. After
training, we then made monthly visits to each imple-
mentation site to ensure correct and consistent usage of
ICF methods.
A bi-monthly transportation service was set up to
transport sputum specimens from clinics to the district
hospital laboratory and to return results.
A standardised reporting and monitoring system
recorded patient demographics and clinical information
Figure 1 Intensified case finding programme and pathway
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and treatment initiation (Figure 2). This permitted
ongoing assessment of programme performance and
losses to follow up amongst the screening cohorts.
One full-time registered nurse and one part-time TB/
HIV Outreach Coordinator were hired to coordinate the
regional ICF programme and provide transportation.
The equipment required for the programme included
sputum pots, TB screening tools and patient registers
provided by the National TB Programme. The registered
nurse, outreach coordinator and hospital TB department
coordinating the programme all received cellular phones
with monthly credit. Clinics were given monthly cellular
telephone credit to contact the hospital.
Study population and data collection
The ICF programme started in February 2009. We fol-
lowed a cohort of HIV positive patients screened as part
of routine HIV testing or pre-ART services in a three
month period (March to May 2009) at the district hos-
pital (n = 1129) or community clinics (n = 338). The
patient follow-up period ended at the end of July 2009.
Figure 2 Summary of intensified case finding outcomes by screening cohort
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pre-ART services at the district hospital or community
clinics were included in the analysis.
Patients on antiretroviral treatment were excluded as TB
screening had previously been established within the ART
service. Hospital inpatients were not included. Other
exclusion criteria included those already diagnosed with
TB, currently on TB treatment, or having taken treatment
for TB in within 3 months before screening (n = 19).
Analysis
We calculated the proportion of smear positives and the
number needed to screen (NNS) to achieve one smear-
positive diagnosis or treatment initiation to determine
the ICF yield. We analysed the probability of initiating
TB treatment within one month of diagnosis using
logistic regression. Proportions of patients starting TB
treatment after diagnosis was analysed using Yates cor-
rected chi-square tests. Distance, time and cost of travel
were estimated using a two-week sample of clinic atten-
dees (n = 85). Data on patient demographics, residence,
and outcomes of TB screening were derived from routi-
nely collected information on TB registers. Travel costs
were derived from local bus companies and healthcare
workers and converted from local currency (Emalan-
geni) to international dolla r s( $ p o p )u s i n gW o r l dB a n k
conversion rates.
This study was reviewed by the ethics committee at
the University of Leeds and approved by the Swaziland
Ministry of Health and Social Welfare. It was an evalua-
tion and audit of routine service development rather
than a research study and individual patient consent
was not required
Results
Performance through the pathway
During the 3 month period, 1467 HIV patients were
screened for TB in the ICF programme. Of those screened,
365 (25%) were identified as TB suspects. The major loss
in follow up occurred prior to laboratory diagnosis (Figure
2). Of those with symptoms of TB, only 172 (47%) pro-
vided sputum samples for smear analysis. Twenty eight
individuals (16%) submitted sputum-smear positive sam-
ples. Amongst those who were smear positive, 24 (86%)
commenced treatment, 3 died prior to commencing treat-
ment, and 1 delayed treatment beyond one month of diag-
nosis (Figure 2). Using the total number eligible for
screening (n = 1467) as a denominator, the proportion
diagnosed with smear positive TB was 2% (28/1467) over-
all giving a number needed to screen (NNS) of 52.
Comparison of hospital and clinic sites
The proportion of individuals identified as TB suspects
was significantly higher in community clinics (c.49%)
than at the district hospital (c.18%); chi squared 133; p
< 0.001. There was no significant difference between the
hospital (20%) and clinic sites (12%) of those who were
smear positive amongst those who submitted sputum.
(X2 = 1.55; p = 0.21).
The proportion of people starting treatment within one
month of a smear positive diagnosis was not significantly
different between the hospital and clinic groups (90% and
83%) (x2 = 0.024; df = 1; p = 0.8769)( F i g u r e2 ) .
The number needed to screen (NNS) in order to
detect one new case of AFB smear positive TB was 34
cases in clinics as compared with 63 cases in the hospi-
tal. The NNS for one treatment initiation was 38 in
clinics and 75 in hospital.
Demographics and characteristics of individuals
diagnosed with TB
Those screened at clinics were significantly more likely
to be female, older, and live more geographically remote
to the district hospital (p < 0.001) (Table 1). The age
and sex of participants approximated the regional and
national HIV positive and TB populations. Older age
(OR (95%CI) for 10 years = 1.11 (1.02-1.20); p = 0.018)
and male gender (OR (95% CI) = 1.78 (1.36 - 2.34); p<
0.001) were predictors of a smear positive result in both
hospital and clinic settings.
Discussion
This evaluation study found that ICF can be feasibly
implemented into routine HIV services. Provision of ICF
in both clinic and hospital settings was effective in
detecting smear positive TB. The proportion of observed
smear positives amongst those in the study was 2%
(NNS 52). This is lower than findings from other stu-
dies. In a systematic review, ICF in ART and medical
clinics in sub Saharan Africa had a median detection
rate of 8.6% (range 3.6-24.7) with a NNS of 12 (4-28)
[5]. The lower proportion of observed smear positives
m a yb ee x p l a i n e db yar e l i a n c eo ns p u t u ms m e a rd i a g -
nosis alone (without the use of chest x-ray), or that
screening criteria was not sufficiently sensitive to detect
cases. It is important to note that our observed analysis
excluded over half (53%) of TB suspects who did not
return sputum specimens. If the assumption was made
that those who did not submit sputum specimens were
just as likely to have smear positive TB as those who
did submit, then the yield of smear positives would be
4% (61/1467) which is similar to rates found in other
published studies [5]. However, this would not have
reflected the reality of implementing an ICF programme
in a low resource, rural setting and the practical mes-
sages about motivating patients to provide specimens.
The proportion of individuals screened being identi-
fied as TB suspects was significantly higher in the clinics
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nation could be that staff were more motivated or there
was more rigorous application of the screening tool at
some clinics.
The key barrier in the pathway was that 53% of TB
suspects did not return sputum specimens. This drop
out was in the ICF programme and not overall HIV fol-
low up care. The potential reasons include: financial and
geographical barriers for patients in returning sputum to
clinics or hospital, difficulty in producing sputum, or
patients not prioritising this. One potential solution
would be increased use of spot sputums, sputum induc-
tion and, at the hospital, real time microscopy to reduce
the loss between submission and diagnosis.
In this ICF programme, TB treatment was available
only at major centres including the district hospital. To
maximise the benefits of ICF in community clinics, it
may be necessary to decentralise TB treatment as well
as screening.
Patient demographics showed that providing ICF at
both clinics and the hospital may improve access to a
wider section of people living with HIV. Clinic-based
ICF improves TB detection rates in specific populations,
namely rural and older. Therefore, providing ICF at
both sites may provide additional benefit in early detec-
tion and reduced transmission among populations
which are inter-connected.
Strengths of evaluation
This was a pragmatic evaluation in a low resource set-
ting which provides timely evidence about an important
new public health programme. Evidence based research
must draw on a range of designs and methodologies in
order to inform policy and practice. We sought to bal-
ance research rigour with practical implementation and
evaluation. We chose to simplify the intervention, mini-
mise data collection and not to place additional work-
load demands onto an already overstretched and
understaffed primary health care service. Our goal was
to incorporate ICF as an integral part of TB/HIV care
within the existing services and our results are likely to
be generalisable to real world rural African settings.
Limitations of evaluation
Key issues included the study design and methodology,
the small sample size of those initiating TB treatment
and our ability to follow those patients beyond treat-
ment initiation. These factors limited our ability to
interpret findings with certainty and to provide wider
generalisations. Extending the time period, following the
patients through to treatment completion, and addi-
tional qualitative work would have provided additional
evidence and a greater understanding of the facilitators
and barriers to implementation.
We were unable to record the denominator or total
number of people eligible during this time period, due
to the reliance on routine data and the limitations of
data quality. It may be that these patients would present
clinically over time irrespective of ICF but our aim was
to detect these earlier before clinical deterioration and
further onwards transmission. We were also unable to
distinguish or disaggregate newly diagnosed HIV posi-
tive patients from those with a known diagnosis who
had been in care. Because of this, it is difficult to
Table 1 Characteristics by screening location and comparison by univariate logistic regression
Patient Characteristic District hospital
n = 1129
Community Clinic
n = 338
Univariate analysis
No (%)/Mean (S.D) No (%)/Mean (S.D) P-value‡
Gender 0.000
Male 411 (36.4%) 80 (23.7%)
Female 717 (63.6%) 258 (76.3%)
Age (yrs) 35.2 (14.6) 38.8 (13.8) 0.000
Region 0.000
Lubombo 997 (88.3%) 313 (92.6%)
Other region 122 (10.8%) 1 (0.3%)
Unknown* 10 (0.9%) 24 (7.1%)
Distance to screening centre (km) 39.9 (28.8) 18.55 (13.50) 0.000
Cost of travel to screening centre ($Int***) 5.0 (3.8) 3.6 (0.0) 0.000
Remoteness to district hospital (km) 39.9 (28.8) 56.24 (18.33) 0.001
Cost of travel to district hospital ($Int***) 5.0 (3.8) 8.3 (3.1) 0.000
‡ Wald test
* Patients with no data on region or residence did not differ significantly from the remainder of the sample across any other variable.
*** International dollars adjusted for purchasing power parity
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detected amongst those screened and the higher propor-
tion (16%) of smear positives amongst TB suspects.
Another limitation was our analysis of smear positive
TB outcomes only. We followed the 28 smear positive
patients through to treatment initiation, rather than fol-
lowing up the outcomes all 365 TB suspects, or in fact,
all 1467 people screened. A recent systematic review
found that, amongst HIV co-infected patients, a signifi-
cant proportion of TB cases may remain asymptomatic
or present with minor symptoms [5]. Alternative
approaches include requesting sputums from all new
HIV diagnoses regardless of symptoms or to perform
additional investigations such as sputum culture or chest
radiography on those with positive screening. This mea-
sure may have increased the yield of TB cases detected;
however, it was balanced against the additional costs.
Several challenges to sustainability and scale up were
identified by this study. Transportation, laboratory facil-
ities and reporting systems remain key challenges for
service expansion. ICF is reliant on having an effective
and efficient TB programme for patients to enter and
ensuring that patients complete treatment. Expanding
and scaling up ICF nationally may pose an additional
strain on existing services. The Swaziland National TB
Control Programme is currently faced with human and
financial resource constraints, insufficient TB/HIV coor-
dination, and limited laboratory capacity. ICF must be
strengthened alongside our efforts to improve the neces-
sary capacity, infrastructure and efficiently of the
National TB Control Programme.
Conclusions
This study found that ICF can be feasibly implemented
into routine TB/HIV services in clinics and hospitals in
a rural high HIV prevalence setting. ICF was as effective
in clinics as in the district hospital and was potentially
more accessible to an underserved rural population. The
lessons from this study may inform policy and practice
in Swaziland and also inform the evidence base on the
facilitators and challenges to integrated TB/HIV care in
other high prevalence HIV settings across Southern
Africa.
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